|
|
Volumn 12, Issue 3, 1999, Pages 137-145
|
|
Development of dopamine transporter imaging agents for the diagnosis of Parkinson's disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER;
[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M;
ALTROPANE;
COCAINE;
DOPAMINE RECEPTOR;
DOPAMINE TRANSPORTER;
DOPASCAN;
IODINE 123;
IOFLUPANE;
IOMETOPANE;
RADIOISOTOPE;
RADIOPHARMACEUTICAL AGENT;
TECHNEPINE;
TECHNETIUM 99M;
TROPANE DERIVATIVE;
UNCLASSIFIED DRUG;
BRAIN REGION;
DIAGNOSTIC VALUE;
DIFFERENTIAL DIAGNOSIS;
DOPAMINERGIC NERVE CELL;
DOPAMINERGIC SYSTEM;
DRUG COST;
DRUG HALF LIFE;
DRUG STRUCTURE;
ESSENTIAL TREMOR;
HUMAN;
MEDICAL LITERATURE;
PARKINSON DISEASE;
PARKINSONISM;
POSITRON EMISSION TOMOGRAPHY;
RECEPTOR BINDING;
REVIEW;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
STRUCTURE ACTIVITY RELATION;
|
|
EID: 0032958334
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: 10.1358/dnp.1999.12.3.658764 Document Type: Review |
|
Times cited : (8)
|
|
References (46)
|
